JAZZ vs PHR · P/E 1988, rev $2.28B vs rev $480.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Phreesia Inc (PHR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Phreesia Inc (PHR) is a health information services company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PHR revenue for 2026-01-31 was $480.6M. Net income was $2.3M. Revenue was up 14.5% from 2025-01-31 to 2026-01-31. PHR currently screens at market cap $1.70B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PHR currently screens at market cap $1.70B.
Not investment advice. Open the JAZZ and PHR stock pages for the full models.
Not investment advice.